NP35925 Cardiovascular & Respiratory Medicines
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Contract (Goods)
- Duration
- not specified
- Value
- £14K-£30M
- Sector
- HEALTH
- Published
- 06 May 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
1 buyer
- NHS National Services Scotland NSS Edinburgh
42 suppliers
- Martindale Pharma Romford
- Aguettant Bristol
- Glaxosmithkline Brentford
- Aventis Pharma Guildford
- Day Lewis Medical Croydon
- Techdow Pharma England Guildford
- Venipharm Gerrards Cross
- Accord London
- Chiesi Manchester
- Mercury Pharmaceuticals London
- Stada UK Thornton & Ross Huddersfield
- Selective Supplies Haywards Heath
- Aspire Elgin
- CST Pharma Walsall
- Glenmark Pharmaceuticals Europe Watford
- Kent Pharmaceuticals Ashford
- Sandoz Surrey
- Wockhardt Wrexham
- Colonis Pharma Royal Tunbride Wells
- Zentiva Pharma London
- Pfizer Tadworth
- Northumbria Healthcare NHS Trust Newcastle upon Tyne
- Celix Pharma London
- Hikma Pharmaceutical London
- DR Reddys Laboratories Cambridge
- MSN Labs Letchworth Garden City
- Perennial Pharma Hatfield
- Viatris UK Healthcare Hatfield
- Bowmed Ibisqus Wrexham
- Bristol Laboratories Berkhamsted
- Consilient Health Richmond
- Focus Pharmaceuticals Burton upon Trent
- Galvany Pharma Stevenage
- Gennisium Pharma Sas Vitrolles
- Grindeks Kalceks Norwich
- Hameln Pharma Gloucester
- Macure Pharma Aps København Nv
- Morningside Pharmaceuticals Leicester
- Ranbaxy London
- Rosemont Pharmaceuticals Leeds
- Stirling Anglian Pharmaceuticals Glasgow
- Syrimed Kingston upon Thames
Description
This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Lot Division
2 | Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
3 | Epinephrine (Adrenaline) Pre-Filled Syringes Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
5 | Enoxaparin Sodium Injection Supply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
7 | Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
8 | Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
9 | Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
10 | Nifedipine Modified-Release (M/R) Capsules and Tablets Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
12 | Branded and Branded Generic Inhalers Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
13 | Iloprost Medicines Supply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
14 | Dalteparin Injections Supply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT. |
15 | Tinzaparin Sodium Injections Supply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a lot basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
16 | Icatibant Solution for Injection Supply of Icatibant Solution for Injection to NHS Scotland. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT. |
17 | Treprostinil Injection Supply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority intends awarding an unranked multi supplier framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT. |
18 | Direct Acting Oral Anticoagulants (DOACs) Supply of Direct Acting Oral Anticoagulants (DOACs) to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT. |
19 | All Other Cardiovascular & Respiratory Medicines Supply of All Other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line will be treated as an individual Lot. The Authority intends awarding each product line to a single Framework Participant. Full details can be found within the ITT. |
Award Detail
1 | Martindale Pharma (Romford)
|
2 | Aguettant (Bristol)
|
3 | Glaxosmithkline (Brentford)
|
4 | Aventis Pharma (Guildford)
|
5 | Day Lewis Medical (Croydon)
|
6 | Techdow Pharma England (Guildford)
|
7 | Venipharm (Gerrards Cross)
|
8 | Martindale Pharma (Romford)
|
9 | Accord (London)
|
10 | Chiesi (Manchester)
|
11 | Mercury Pharmaceuticals (London)
|
12 | Stada UK Thornton & Ross (Huddersfield)
|
13 | Martindale Pharma (Romford)
|
14 | Aventis Pharma (Guildford)
|
15 | Stada UK Thornton & Ross (Huddersfield)
|
16 | Day Lewis Medical (Croydon)
|
17 | Selective Supplies (Haywards Heath)
|
18 | Accord (London)
|
19 | Aspire (Elgin)
|
20 | Chiesi (Manchester)
|
21 | CST Pharma (Walsall)
|
22 | Day Lewis Medical (Croydon)
|
23 | Glenmark Pharmaceuticals Europe (Watford)
|
24 | Kent Pharmaceuticals (Ashford)
|
25 | Sandoz (Surrey)
|
26 | Selective Supplies (Haywards Heath)
|
27 | Stada UK Thornton & Ross (Huddersfield)
|
28 | Wockhardt (Wrexham)
|
29 | Glaxosmithkline (Brentford)
|
30 | Colonis Pharma (Royal Tunbride Wells)
|
31 | Zentiva Pharma (London)
|
32 | Pfizer (Tadworth)
|
33 | Northumbria Healthcare NHS Trust (Newcastle upon Tyne)
|
34 | Martindale Pharma (Romford)
|
35 | Celix Pharma (London)
|
36 | Glenmark Pharmaceuticals Europe (Watford)
|
37 | Hikma Pharmaceutical (London)
|
38 | Stada UK Thornton & Ross (Huddersfield)
|
39 | Wockhardt (Wrexham)
|
40 | DR Reddys Laboratories (Cambridge)
|
41 | Aspire (Elgin)
|
42 | Celix Pharma (London)
|
43 | Glenmark Pharmaceuticals Europe (Watford)
|
44 | MSN Labs (Letchworth Garden City)
|
45 | Perennial Pharma (Hatfield)
|
46 | Sandoz (Surrey)
|
47 | Stada UK Thornton & Ross (Huddersfield)
|
48 | Viatris UK Healthcare (Hatfield)
|
49 | Wockhardt (Wrexham)
|
50 | Zentiva Pharma (London)
|
51 | Martindale Pharma (Romford)
|
52 | Accord (London)
|
53 | Aguettant (Bristol)
|
54 | Aspire (Elgin)
|
55 | Aventis Pharma (Guildford)
|
56 | Bowmed Ibisqus (Wrexham)
|
57 | Bristol Laboratories (Berkhamsted)
|
58 | Colonis Pharma (Royal Tunbride Wells)
|
59 | Consilient Health (Richmond)
|
60 | CST Pharma (Walsall)
|
61 | Day Lewis Medical (Croydon)
|
62 | Focus Pharmaceuticals (Burton upon Trent)
|
63 | Galvany Pharma (Stevenage)
|
64 | Gennisium Pharma Sas (Vitrolles)
|
65 | Glenmark Pharmaceuticals Europe (Watford)
|
66 | Grindeks Kalceks (Norwich)
|
67 | Hameln Pharma (Gloucester)
|
68 | Hikma Pharmaceutical (London)
|
69 | Kent Pharmaceuticals (Ashford)
|
70 | Macure Pharma Aps (København Nv)
|
71 | Mercury Pharmaceuticals (London)
|
72 | Morningside Pharmaceuticals (Leicester)
|
73 | MSN Labs (Letchworth Garden City)
|
74 | Pfizer (Tadworth)
|
75 | Ranbaxy (London)
|
76 | Rosemont Pharmaceuticals (Leeds)
|
77 | Sandoz (Surrey)
|
78 | Stirling Anglian Pharmaceuticals (Glasgow)
|
79 | Syrimed (Kingston upon Thames)
|
80 | Stada UK Thornton & Ross (Huddersfield)
|
81 | Viatris UK Healthcare (Hatfield)
|
82 | Wockhardt (Wrexham)
|
83 | Zentiva Pharma (London)
|
84 | Focus Pharmaceuticals (Burton upon Trent)
|
85 | Stada UK Thornton & Ross (Huddersfield)
|
Award Criteria
Logistics | 5 |
price | 95 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the thirty six (36) month contract duration and the twenty four (24) month extension period of the framework agreement. (SC Ref:795893)
Reference
- ocds-h6vhtk-04afa6
- FTS 019020-2025